Compliance certificate under regulation 74(5) of SEBI DP Regulation for the Quarter ended on March 31, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bharat Parenterals has submitted a routine compliance certificate to BSE under Regulation 74(5) of SEBI's Depositories and Participants Regulations, 2018. The certificate, issued by the company's Registrar and Share Transfer Agent (Adroit Corporate Services), confirms that all securities received from depository participants for dematerialization during the quarter ended March 31, 2025 were properly confirmed to the depositories. It also confirms that physical share certificates received for demat were mutilated and cancelled, with the depository's name recorded as the registered owner within the required 15-day timeline.
This is a standard procedural filing with no impact on the company's operations, financials, or stock price. Investors should view this as routine housekeeping compliance with no trading signal.